This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Corpus, R. A. Articles by O'Neill, W. W. Search for Related Content PubMed PubMed Citation Articles by Corpus, R. A. Articles by O'Neill, W. W.

Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention

Roberto A. Corpus, MD^*,*, Peter B. George, MD, John A. House, MS^*, Simon R. Dixon, MBChB, Steven C. Ajluni, MD, FACC, William H. Devlin, MD, FACC, Gerald C. Timmis, MD, FACC, Mamtha Balasubramaniam, MS and William W. O'Neill, MD, FACC

^* Division of Cardiology and Biostatistics, Mid America Heart Institute, St. Luke's Hospital, Kansas City, Missouri, USA
Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan, USA

View larger version (23K): [in a new window]   Figure 1 Incidence of target vessel revascularization in diabetic and nondiabetic patients. A1c = hemoglobin A1c.

View larger version (27K): [in a new window]   Figure 2 Incidence of target vessel revascularization according to treatment regimen.